These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 8627570

  • 1. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC, Wu D, Soong Y, Yee JS, Szeto HH.
    J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
    [Abstract] [Full Text] [Related]

  • 2. Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism.
    Taylor CC, Wu D, Soong Y, Yee JS, Szeto HH.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):416-21. PubMed ID: 8996223
    [Abstract] [Full Text] [Related]

  • 3. Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration.
    Taylor CC, Wu D, Soong Y, Yee JS, Szeto HH.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):129-35. PubMed ID: 9103489
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
    Belkowski SM, Alicea C, Eisenstein TK, Adler MW, Rogers TJ.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124
    [Abstract] [Full Text] [Related]

  • 5. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 6. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [Abstract] [Full Text] [Related]

  • 7. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
    Ignar DM, Kuhn CM.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1287-95. PubMed ID: 2175800
    [Abstract] [Full Text] [Related]

  • 8. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG, Zhang F, Jin XL, Liu-Chen LY.
    J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
    [Abstract] [Full Text] [Related]

  • 9. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C, Vargas ML, Fuente T, Milanés MV.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Site and mechanism of action of dynorphin A-(1-13) and N-methyl-D-aspartate on ACTH release in fetal sheep.
    Nardo L, Soong Y, Wu D, Young IR, Walker D, Szeto HH.
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1301-7. PubMed ID: 12006360
    [Abstract] [Full Text] [Related]

  • 12. Differential mechanisms of ovine fetal pituitary stimulation by a selective kappa-opioid agonist and by dynorphin.
    Taylor CC, WU D, Soong Y, Yee JS, Szeto HH.
    Neuroendocrinology; 1996 Dec; 64(6):419-24. PubMed ID: 8990074
    [Abstract] [Full Text] [Related]

  • 13. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S, Kim HS, Wood PL.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [Abstract] [Full Text] [Related]

  • 14. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
    Bian JS, Pei JM, Cheung CS, Zhang WM, Wong TM.
    J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M, Cover PO, Poyser RH, Buckingham JC.
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [Abstract] [Full Text] [Related]

  • 16. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ, Morris BJ, Herz A.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
    Li JG, Benovic JL, Liu-Chen LY.
    Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
    [Abstract] [Full Text] [Related]

  • 18. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells.
    Zhu J, Luo LY, Mao GF, Ashby B, Liu-Chen LY.
    J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991
    [Abstract] [Full Text] [Related]

  • 19. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C.
    Bian JS, Wang HX, Zhang WM, Wong TM.
    Br J Pharmacol; 1998 Jun; 124(3):600-6. PubMed ID: 9647487
    [Abstract] [Full Text] [Related]

  • 20. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ.
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.